32 / 1851
a) EGFR ligands bind the extracellular domain of the EGFR, induce receptor dimerization
and activate downstream signaling pathways that are crucial for cell survival and proliferation
b) Cetuximab prevents ligand binding to EGFR, thus blocking EGFR signaling
Cetuximab sensitivity
Mechanisms of Resistance to mAB